尿路感染症に対するBRL25000(Clavulanic acid-Amoxicillin)の臨床的検討 (BRL25000(Clavulanic acid-Amoxicillin)<特集>)
スポンサーリンク
概要
- 論文の詳細を見る
BRL25000 was administered to 25 outpatients of the urology department of Kurume University from June 1980 to October 1980 and the results were obtained. The daily dosage for patients with acute uncomplicated cystitis was 1, 125 mg administered t. i. d. for 5-7 days, and for patients with chronic complicated urinary tract infection was 1, 500 mg administered q. i. d. for 7 days.<BR>The response to BRL25000 therapy in 11 patients with acute uncomplicated cystitis was excellent in 7 patients and moderate in 4, an overall effectiveness rate of 100%(11/11). The response in 14 patients with complicated urinary tract infections was excellent in 3 patients, moderate in 2, poor in 7 and unassessable in 2. The effectiveness rate was therefore 41.7%(5/12).<BR>Bacteriologically, 21 out of 26 strains were eliminated, and elimination rate was 80.8%.<BR>Drug-related side effects were found in 2 patients consisting of 1 case of heart burn and 1 of nausea. No laboratory abnomalities attributable to the treatment were found.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.